Nikolic K - Search Results

1

Rational Drug Design of Antineoplastic Agents Using 3D-QSAR, Cheminformatic, and Virtual Screening Approaches.

Vucicevic J, Nikolic K, Mitchell JBO. Vucicevic J, et al. Among authors: nikolic k. Curr Med Chem. 2019;26(21):3874-3889. doi: 10.2174/0929867324666170712115411. Curr Med Chem. 2019. PMID: 28707592 Review.

2

QSAR study of imidazoline antihypertensive drugs.

Nikolic K, Filipic S, Agbaba D. Nikolic K, et al. Bioorg Med Chem. 2008 Aug 1;16(15):7134-40. doi: 10.1016/j.bmc.2008.06.051. Epub 2008 Jun 28. Bioorg Med Chem. 2008. PMID: 18621536

3

Design and QSAR study of analogs of gamma-tocotrienol with enhanced antiproliferative activity against human breast cancer cells.

Nikolic K, Agababa D. Nikolic K, et al. J Mol Graph Model. 2009 Apr;27(7):777-83. doi: 10.1016/j.jmgm.2008.11.007. Epub 2008 Nov 27. J Mol Graph Model. 2009. PMID: 19117779

4

Pharmacophore development and SAR studies of imidazoline receptor ligands.

Nikolic K, Agbaba D. Nikolic K, et al. Mini Rev Med Chem. 2012 Dec;12(14):1542-55. doi: 10.2174/138955712803832636. Mini Rev Med Chem. 2012. PMID: 22512575 Review.

5

Imidazoline-1 receptor ligands as apoptotic agents: pharmacophore modeling and virtual docking study.

Nikolic K, Veljkovic N, Gemovic B, Srdic-Rajic T, Agbaba D. Nikolic K, et al. Comb Chem High Throughput Screen. 2013 May;16(4):298-319. doi: 10.2174/1386207311316040004. Comb Chem High Throughput Screen. 2013. PMID: 23360165

6

Phenylpropiophenone derivatives as potential anticancer agents: synthesis, biological evaluation and quantitative structure-activity relationship study.

Ivković BM, Nikolic K, Ilić BB, Žižak ŽS, Novaković RB, Čudina OA, Vladimirov SM. Ivković BM, et al. Among authors: nikolic k. Eur J Med Chem. 2013 May;63:239-55. doi: 10.1016/j.ejmech.2013.02.013. Epub 2013 Feb 20. Eur J Med Chem. 2013. PMID: 23501110

7

Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.

Bautista-Aguilera OM, Esteban G, Bolea I, Nikolic K, Agbaba D, Moraleda I, Iriepa I, Samadi A, Soriano E, Unzeta M, Marco-Contelles J. Bautista-Aguilera OM, et al. Among authors: nikolic k. Eur J Med Chem. 2014 Mar 21;75:82-95. doi: 10.1016/j.ejmech.2013.12.028. Epub 2014 Jan 27. Eur J Med Chem. 2014. PMID: 24530494

8

Predicting targets of compounds against neurological diseases using cheminformatic methodology.

Nikolic K, Mavridis L, Bautista-Aguilera OM, Marco-Contelles J, Stark H, do Carmo Carreiras M, Rossi I, Massarelli P, Agbaba D, Ramsay RR, Mitchell JB. Nikolic K, et al. J Comput Aided Mol Des. 2015 Feb;29(2):183-98. doi: 10.1007/s10822-014-9816-1. Epub 2014 Nov 26. J Comput Aided Mol Des. 2015. PMID: 25425329

9

Prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis.

Vucicevic J, Nikolic K, Dobričić V, Agbaba D. Vucicevic J, et al. Among authors: nikolic k. Eur J Pharm Sci. 2015 Feb 20;68:94-105. doi: 10.1016/j.ejps.2014.12.014. Epub 2014 Dec 24. Eur J Pharm Sci. 2015. PMID: 25542610

10

Quantitative structure-retention relationship of selected imidazoline derivatives on α1-acid glycoprotein column.

Filipic S, Ruzic D, Vucicevic J, Nikolic K, Agbaba D. Filipic S, et al. Among authors: nikolic k. J Pharm Biomed Anal. 2016 Aug 5;127:101-11. doi: 10.1016/j.jpba.2016.02.053. Epub 2016 Mar 3. J Pharm Biomed Anal. 2016. PMID: 26968888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page